SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-21-016771
Filing Date
2021-03-22
Accepted
2021-03-22 06:09:44
Documents
6

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea138106-8k_neostherapeutics.htm 425 50708
2 FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NEOS THERAPEUTICS, IN ea138106ex3-1_neostherap.htm EX-3.1 6544
3 SECOND AMENDED AND RESTATED BYLAWS OF NEOS THERAPEUTICS, INC ea138106ex3-2_neostherap.htm EX-3.2 88734
4 CONSENT, WAIVER AND SIXTH AMENDMENT TO FACILITY AGREEMENT, BY AND AMONG AYTU BIO ea138106ex10-1_neostherap.htm EX-10.1 607158
5 CONSENT, WAIVER AND AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT, BY AND AMONG ea138106ex10-2_neostherap.htm EX-10.2 45933
6 PRESS RELEASE DATED MARCH 22, 2021 ea138106ex99-1_neostherap.htm EX-99.1 16319
  Complete submission text file 0001213900-21-016771.txt   816992
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filed by) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Subject) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37508 | Film No.: 21759795
SIC: 2834 Pharmaceutical Preparations